Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “CytomX Therapeutics, Inc.”

62 pharma patents match "CytomX Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 62
Index total 30,257
Page 3 / 3

Quick answer

This filtered view shows 62 pharmaceutical patents matching "CytomX Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

62 results for “CytomX Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 9688748

    Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Jun 27, 2017 · Expires Jun 22, 2037

    granted
  2. US 9644016

    Soluble notch receptor proproteins and methods of use thereof

    CytomX Therapeutics, Inc. · Granted May 9, 2017 · Expires May 4, 2037

    granted
  3. US 9562073

    Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Feb 7, 2017 · Expires Feb 2, 2037

    granted
  4. US 9545442

    Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted
  5. US 9540440

    Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  6. US 9517276

    Compositions and methods for conjugating activatable antibodies

    CytomX Therapeutics, Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036

    granted
  7. US 9487590

    Activatable antibodies that bind interleukin-6 receptor and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  8. US 9453078

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted
  9. US 9127053

    Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted
  10. US 9120853

    Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Sep 1, 2015 · Expires Aug 27, 2035

    granted
  11. US 8993266

    Proproteins activatable interferon alpha

    CytomX Therapeutics, Inc. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted
  12. US 8563269

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  13. US 8513390

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted
  14. US 8399219

    Protease activatable interferon alpha proprotein

    CytomX Therapeutics, Inc. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted